[Congressional Record Volume 163, Number 6 (Tuesday, January 10, 2017)]
[Senate]
[Page S218]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 97. Mr. BLUMENTHAL (for himself and Ms. Klobuchar) submitted an 
amendment intended to be proposed by him to the concurrent resolution 
S. Con. Res. 3, setting forth the congressional budget for the United 
States Government for fiscal year 2017 and setting forth the 
appropriate budgetary levels for fiscal years 2018 through 2026; which 
was ordered to lie on the table; as follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO IMPROVING 
                   DRUG PRICING TRANSPARENCY FOR CONSUMERS.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution 
     for one or more bills, joint resolutions, amendments, 
     amendments between the Houses, motions, or conference reports 
     relating to improving drug pricing transparency for consumers 
     by the amounts provided in such legislation for those 
     purposes, provided that such legislation would not increase 
     the deficit over either the period of the total of fiscal 
     years 2017 through 2021 or the period of the total of fiscal 
     years 2017 through 2026.
                                 ______